Abstract
Taurine is abundant in various tissues including the brain, muscle, heart, spleen, liver and kidney with various physiological functions. Since taurine is produced by cysteine sulfinic acid decarboxylase (CSAD) in the liver and kidney, taurine-deficient mice without CSAD have been investigated for abnormal physiological functions such as retinal development, immune, pancreatic and liver function. In this study, the behavioral effects and abnormal brain development caused by low taurine in the developing brain were examined. In neonatal brains of homozygous CSAD knockout mice (HO), taurine was reduced by 85%, compared to wild-type mice (WT). Taurine was reduced by 35% in the brains of 2 month-old HO, compared to WT. Anxiety, motor coordination and autistic-like behaviors were evaluated at 2 months of age using five behavioral tests: elevated plus maze, open field, social approach, marble burying and accelerating rotarod. Mice were tested from 3 groups including WT, HO and HO with oral treatment of 0.2% taurine in the drinking water (HOT). HOT were born from HO dams treated with taurine from before pregnancy and were continuously treated with taurine in the drinking water after weaning. The taurine levels in the brain and plasma of HOT were restored to WT at 2 months of age. Taurine-deficiency did not lead to changes in autistic-like behaviors as the HO were not significantly different from WT in marble burying and social approach. However, taurine-deficiency increased anxiety-like behavior in HO in the elevated plus maze and open field, compared to WT. Taurine treatment significantly restored the HOT to WT levels of anxiety-like behavior in the elevated plus maze. However, changes in exploratory activity in the open field were not improved with taurine treatment. There was a slight difference in motor ability as the WT mice stayed on the accelerating rotarod longer that the HO and HOT, but the difference was significant in the HOT during the first trial only, compared to WT.
These data support hypothesis that taurine is essential for the emotional development of the brain. First, taurine is remarkably low in the neonatal brain of HO, compared to the adult brain of HO. Second, taurine treatment in HO partially improves anxiety-like behavior to WT.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CSAD:
-
cysteine sulfinic acid decarboxylase
- CSAD KO:
-
cysteine sulfinic acid decarboxylase knock-out mice
- CDO:
-
cysteine dioxygenase
- CDO KO:
-
cysteine dioxygenase knock-out mice
- ADO:
-
cysteamine (2-aminoethanethiol) dioxygenase
- GADL 1:
-
glutamate decarboxylase-like 1
- GADL 1 KO:
-
glutamate decarboxylase-like 1 knock-out mice
- TauT:
-
taurine transporter
- TauT KO:
-
taurine transporter knock-out mice
- WT:
-
wild-type mice (CSAD+/+)
- HT:
-
heterozygotic mice (CSAD+/−)
- HO:
-
homozygotic mice (CSAD−/−)
- HOT:
-
homozygotic mice treated with 0.2% taurine in the drinking water
- ASD:
-
autistic spectrum disorder
References
Aerts L, Van Assche GA (2002) Taurine and taurine-deficiency in the perinatal period. J Perinat Med 30(4):281–286
Aldred S, Moore KM, Fitzgerald M, Waring RH (2003) Plasma amino acid levels in children with autism and their families. J Autism Dev Disord 33(1):93–97
Anchan D, Clark S, Polland K, Vasudevan N (2014) GPR30 activation decreases anxiety in the open field test but not in the elevated plus maze test in female mice. Brain Behav 4(1):51–59
Arnold GL, Hyman SL, Mooney RA, Kirby RS (2003) Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. J Autism Dev Disord 33(4):449–454
Asano A, Roman HB, Hirschberger LL, Ushiyama A, Nelson JL, Hinchman MM, Stipanuk MH, Travis AJ (2018) Cysteine dioxygenase is essential for mouse sperm osmoadaptation and male fertility. FEBS JFEBS J 285(10):1827–1839
Barua S, Chadman KK, Kuizon S, Buenaventura D, Stapley NW, Ruocco F, Begum U, Guariglia SR, Brown WT, Junaid MA (2014) Increasing maternal or post-weaning folic acid alters gene expression and moderately changes behavior in the offspring. PLoS One 9(7):e101674
Chadman KK (2011) Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacol Biochem Behav 97(3):586–594
Chadman KK, Gong S, Scattoni M, Boltuck S, Gandhy SU, Heintz N, Crawley J (2008) Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res 1(3):147–158
Chen SW, Kong WX, Zhang YJ, Li YL, Mi XJ, Mu XS (2004) Possible anxiolytic effects of taurine in the mouse elevated plus-maze. Life Sci 75(12):1503–1511
Dela Rosa J, Stipanuk MH (1985) Evidence for a rate-limiting role of cysteine sulfinate decarboxylase activity in taurine biosynthesis in vivo. Comp Biochem Physiol 81(3):565–571
Dominy JE, Simmons CR, Hirshberger LL, Hwang J, Coloso RM, Stipanuk MH (2007) Discovery and characterization of a second mammalian thiol dioxygenase, cysteamine dioxygenase. J Biol Chem 282:25189–25198
Elidrissi A, L’Amoreaux WJ (2008) Selective resistance of taurine-fed mice to isoniazide-potentiated seizures: in vivo functional test for the activity of glutamic acid decarboxylase. Neuroscience 156:693–699
Elidrissi A, Boukarrou L, Heany W, Malliaros G, Sangdee C, Neuwirth L (2009a) Effects of taurine on anxiety-like and locomotor behavior of mice. Taurine improves learning and retention in aged mice. Adv Exp Med Biol 643:207–215
Elidrissi A, Boukarrou L, Dobkin C, Brown WT (2009b) Taurine improves cognitive functions in a mouse model of fragile X syndrome. Adv Exp Med Biol 643:192–199
Franconi F, Diana G, Fortuna A, Galietta G, Trombetta G, Valentini G, Seghieri G, Loizzo A (2004) Taurine administration during lactation modifies hippocampal CA1 neurotransmission and behavioural programming in adult male mice. Brain Res Bull 63(6):491–497
Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR (2009) Prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res 34:386–393
Ghanizadeh A (2013) Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism. Dis Markers 35(5):281–186
Huxtable RJ (2000) Expanding the circle 1975–1999: sulfur biochemistry and insights on the biological functions of taurine. Adv Exp Med Biol 483:1–25
Imaki H, Neuringer M, Sturman JA (1996) Long-term effects on retina of rhesus monkeys fed taurine-free human infant formula. In: Huxtable R (ed) Taurine 2. Plenum Press, New York, pp 351–360
Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M, Schaffer SW, Fujio Y, Azuma J (2008) Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 44:927–937
Jenness R (1979) The composition of human milk. Semin Perinatol 3(3):225–239
Kang YS, Ohtsuki S, Takanaga H, Tomi M, Terasaki T (2002) Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-alpha, taurine and hypertonicity. J Neurochem 83:1188–1895
Kong WX, Chen SW, Li YL, Zhang YJ, Wang R, Min L, Mi X (2006) Effects of taurine on rat behaviors in three anxiety models. Pharmacol Biochem Behav 83(2):271–276
Lanza A, Colombatto S (2008) Transport of amino acids through the placenta and their role. Amino Acids 34(4):517–523
Laurence JA, Fatemi SH (2005) Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 4:206–210
Liu F, Teng HY, Liu J, Wang HW, Zeng L, Zhao LF (2014) Antenatal taurine supplementation increases taurine content in intrauterine growth restricted fetal rat brain tissue. Metab Brain Dis 29(3):867–871
Liu F, Liu Y, Liu J, Ma LY (2015) Antenatal taurine improves intrauterine growth-restriced fetal rat brain development which is associated with increasing the activity of PKA-CaMKII/c-fos singal pathway. Neuropediatrics 46(5):299–306
Lu P, Schuller-Levis B, Sturman JA (1991) Distribution of taurine-like immunoreactivity in cerebellum of kittens from taurine-supplemented and taurine deficient mothers. Int J Dev Neurosci 6:621–629
McCool BA, Chappell A (2004) Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is ‘state’ dependent. Behav Brain Res 178(1):70–81
Moreno H, Borjas L, Arrieta A, Saez L, Prassad A, Estevez J, Bonilla E (1992) Clinical heterogeneity of the autistic syndrome: a study of 60 families. Investig Clin 33(1):13–31
Moreno-Fuenmayer H, Borjas L, Arrieta A, Valera V, Socorro-Candanoza L (1996) Plasma excitatory amino acids in autism. Investig Clin 37(2):113–128
Neuwirth LS, Volpe NP, Elidrissi A (2013) Taurine effects on emotional learning and memory in aged mice: neurochemical alterations and differentiation in auditory cued fear and context conditioning. Adv Exp Med Biol 775:195–214
Park E, Park SY, Wang C, Xu J, LaFauci G, Schuller-Levis G (2002) Cloning of murine cysteine sulfinic acid decarboxylase and its mRNA expression in murine tissues. Biochim Biophys Acta 1574:403–406
Park E, Park YS, Dobkin C, Schuller-Levis G (2014) Development of a novel cysteine sulfinic acid decarboxylase knockout mouse: dietary taurine reduces neonatal mortality. J Amino Acids 2014:346809., 1–11. https://doi.org/10.1155/2014/346809
Park E, Park SY, Dobkin C, Schuller-Levis G (2015) A novel cysteine sulfinic acid decarboxylase knock-out mouse: comparison between newborn and weanling mice. Adv Exp Med Biol 803:3–16
Park E, Cohen I, Gonzalez M, Castellano MR, Flory M, Jenkins EC, Brown WT, Schuller-Levis G (2017) Is taurine a biomarker in autistic spectrum disorder? Adv Exp Med Biol 975:3–16
Park E, Park SY, Cho IS, Kim BS, Schuller-Levis G (2017a) A novel cysteine sulfinic acid decarboxylase knock-out mouse: taurine distribution in various tissues with and without taurine supplementation. Adv Exp Med Biol 975:461–474
Park E, Park SY, Cho IS, Kim BS, Schuller-Levis G (2017b) A novel cysteine sulfinic acid decarboxylase knock-out mouse: immune function (II). Adv Exp Med Biol 975:449–460
Pow DV, Sullivan R, Reye P, Hermanussen S (2002) Localization of taurine transports, taurine and (3)H taurine accumulation in the rat retina, pituitary and brain. Glia 37:153–168
Ritvo ER, Freeman AB, Duong T, Robinson H, Guthrie D, Ritvo A (1986) Lower Purkinje cell counts in the cerebella of four autistic subjects: initial finding of the UCLA-NSAC autopsy research report. Am J Psychiatry 143:862–866
Roos S, Powell TL, Jansson T (2004) Human placental taurine transport in uncomplicated and IUGR pregnancies: cellular localization, protein expression and regulation. Am J Physiol Regul Integr Comp Physiol 287:R886–R893
Schaffer SW, Azuma J, Mozaffari M (2009) Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87(2):91–99
Schuller-Levis GB, Park E (2003) Taurine: new implications for an old amino acid. FEMS Microbiol Lett 226:195–202
Schuller-Levis G, Park E (2006) Is taurine a biomarker? Adv Clin Chem 41:1–21
Schuller-Levis G, Gordon R, Wang C, Park S, Park E (2009) Protection of bleomycin-induced fibrosis and inflammation by taurine. Int Immunopharmacol 9:971–977
Sidime F, Philips G, LaMassa N, Park E, Elidrissi A (2017) Glucose homeostasis and retinal histology in CSAD KO mice. Adv Exp Med Biol 975:503–511
Stanford WL, Epp T, Reid T, Rossant J (2006) Gene trapping in embryonic stem cells. Methods Enzymol 420:136–162
Stipanuk MH (2004) Role of the liver in regulation of body cysteine and taurine levels: a brief review. Neurochem Res 29(1):105–110
Sturman JA (1993) Taurine in development. Physiol Rev 73:119–146
Tu WJ, Chen H, He J (2012) Application of LC/MS/MS analysis of plasma amino acids profiles in children with autism. J Clin Bichem and Nutri 51(3):248–249
Ueki I, Roman HB, Valli A, Fieselmann K, Lam J, Peters R, Hirschberger LL, Stipanuk MH (2011) Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide. Am J Physiol Endocrinol Metab 301:E668–E684
Wang Y, Fu W, Liu J (2016) Neurodeveloment in children with intrauterine growth restriction: adverse effects and intervetions. J Matern Fatal Neonatal Med 29(4):660–668
Warsulat U, Heller-Stilb B, Oermann E, Zilles K, Haas H, Lang F, Haessinger D (2007) Phenotype of the taurine transporter knockout mouse. Methods Enzymol 428:439–458
Weidner KL, Buenaventura D, Chadman KK (2014) Mice over-expressing BDNF in forebrain neurons develop an altered behavioral phenotype with age. Behav Brain Res 268:222–228
Wharton BA, Morley R, Isaacs EB, Cole TJ, Lucas A (2004) Low plasma taurine and later neurodevelopment. Arch Dis Child Fetal Neonatal Ed 89(6):F97–F98
Winge I, Teigen K, Fossbakk A, Mahootchi E, Kieppe R, SKoelberg F, Kaempe O, Haavik J (2015) Mammalian CSAD and GADL-1 have distinct biochemical properites and patterns of brain expression. Neurochem Int 90:173–184
Wu GF, Ren S, Tang RY, Xu C, Zhou JQ, Lin SM, Feng Y, Yang QH, Hu JM, Yang JC (2017) Antidepressant effect of taurine in chronic unpredictable mild stress-induced depressive rats. Sci Rep 7(1):4989–4996
Xu Y, Lu P, Imaki H, Sturman JA (1992) Feline maternal deficiency: a quantitative morphometric and immunohistochemical study of newborn visual cortex. Dendron 1:129–145
Zhang CG, Kim SJ (2007) Taurine induces anti-anxiety by activating strychnine-sensitive glycine receptor in vivo. Ann Nutr Metab 51(4):379–386
Acknowledgements
This work was supported by the Office for People with Developmental Disabilities, Albany, NY and Dong A Pharmaceutical Co., LTD, Seoul, Korea. We are thankful to Dr. William Levis and H Cliff Meeker for discussing the research and reviewing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Park, E., Elidrissi, A., Schuller-Levis, G., Chadman, K.K. (2019). Taurine Partially Improves Abnormal Anxiety in Taurine-Deficient Mice. In: Hu, J., Piao, F., Schaffer, S., El Idrissi, A., Wu, JY. (eds) Taurine 11. Advances in Experimental Medicine and Biology, vol 1155. Springer, Singapore. https://doi.org/10.1007/978-981-13-8023-5_76
Download citation
DOI: https://doi.org/10.1007/978-981-13-8023-5_76
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8022-8
Online ISBN: 978-981-13-8023-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)